← Back to Search

Monophasic Action Potential (MAP) Catheter for Ventricular Tachycardia

N/A

Waitlist Available

Led By Neal Bhatia, MD

Research Sponsored by Emory University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up during ablation on day 1

Awards & highlights

Study Summary

This trial will study the electrical properties of heart tissue to better understand ventricular arrhythmias and identify potential areas that may cause them.

Eligible Conditions

Ventricular Tachycardia

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ during ablation on day 1

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~during ablation on day 1

This trial's timeline: 3 weeks for screening, Varies for treatment, and during ablation on day 1 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Conduction Velocity

Waveform Morphology

Secondary outcome measures

Identify mechanisms of slowed conduction at ILAM

Identify surrogate markers

Trial Design

1Treatment groups

Experimental Treatment

Group I: Monophasic Action Potential (MAP) CatheterExperimental Treatment1 Intervention

Participants undergoing ventricular tachycardia ablation per standard of care will also have cellular action potential of the ventricular myocardium assessed with the MAP catheter.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor

1,636 Previous Clinical Trials

2,560,563 Total Patients Enrolled

Neal Bhatia, MDPrincipal InvestigatorEmory University

1 Previous Clinical Trials

80 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still space available for prospective participants in this trial?

"Clinicaltrials.gov reflects that this experiment is currently accepting patients and was originally posted on October 25th 2022, with the last update occurring a day later."

Answered by AI

What is the upper limit for participants in this experiment?

"Affirmative. Clinicaltrials.gov data declares that this investigation, which was first publicized on October 25th 2022 is actively recruiting patients. A total of 10 people must be enrolled from 3 different research centres."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Ventricular Tachycardia Mechanisms

Neal Bhatia 2022. "Ventricular Tachycardia Mechanisms". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05478213.